Bridgepoint Group PLC — Share Issue/Capital Change 2026

Mar 23, 2026

National Storage Mechanism | Additional information

RNS Number : 7138X

Bridgepoint Group plc

23 March 2026

Bridgepoint Group plc

("Bridgepoint" or the "Company")

Issue of Equity and Total Voting Rights

Bridgepoint announces that it intends to issue 1,399,733 ordinary shares of £0.00005 each ("New Ordinary Shares") to satisfy vesting awards granted in prior years under Bridgepoint's Long Term Incentive Plan. The New Ordinary Shares will rank pari passu with existing ordinary shares in issue.

An application has been made for the admission of the New Ordinary Shares to trading on the LSE's main market for listed securities.

Admission is expected to occur on 26 March 2026. 

In conformity with the Financial Conduct Authority's Disclosure and Transparency Rules, Bridgepoint announces that its total issued share capital following the issue of the New Ordinary Shares will comprise:

•	878,071,547 ordinary shares of £0.00005 each with voting rights; and
•	500 deferred shares of £81 each, 1 deferred share of £1, and 1 deferred share of £0.01, each with no voting rights.

Bridgepoint holds no shares in treasury. Following the issue of the New Ordinary Shares the total number of voting rights in the Company will therefore be 878,071,547, and this figure may be used by shareholders at such time as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Bridgepoint under the Disclosure Guidance and Transparency Rules.

ENQUIRIES

Bridgepoint

Analysts and investors Adam Key [email protected] +44 7833 748010	Media Christian Jones [email protected] +44 20 7034 3500

FGS Global (Public Relations Adviser to Bridgepoint)

James Murgatroyd / +44 20 7251 3801 / +44 7768 254 911

Anjali Unnikrishnan / +44 20 7251 3801 / +44 7826 534 233

[email protected]

Issued by Bridgepoint Group plc

LEI: 213800KFNMVI8PDZX472

Registered in England and Wales no. 11443992

Registered office: 5 Marble Arch, London, W1H 7EJ

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOEBGGDXCXDDGLX